View full meeting coverage »

Eyetube Meeting Coverage:

American Glaucoma Society 2020 Annual Meeting



Your 25-second video preview has ended.

to continue watching, please Log In or Register:

Log in / Register

LiGHT: Efficacy and Cost Effectiveness

  Channels: Glaucoma | Posted 1/28/2020

Sarwat Salim, MD, FACS, sits down with Gus Gazzard, MD, FRCOphth, to discuss the Laser in Glaucoma and Ocular Hypertension (LiGHT) trial. Dr. Gazzard details the study design, efficacy data, and cost effectiveness of selective laser trabeculoplasty versus medication.

Clinical Trials • Glaucoma • Ocular Hypertension, OHT • Trabeculoplasty

10 / 14 Series: American Glaucoma Society 2020 Annual Meeting